Stephen C. Glover - 28 Feb 2025 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Spencer Brown, as Attorney-in-Fact
Issuer symbol
PDSB
Transactions as of
28 Feb 2025
Net transactions value
+$25,001
Form type
4
Filing time
03 Mar 2025, 16:45:20 UTC
Previous filing
25 Jun 2024
Next filing
11 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PDSB Common Stock Purchase $25,001 +15,061 +24% $1.66 78,851 28 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Common Warrant Purchase +15,061 15,061 28 Feb 2025 Common Stock 15,061 $1.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above.